RIXIMYO
RIXIMYO
Approved
DIN Number
02498316
Drug Class
Human
Market Date
May 22, 2020
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02498316
AIG Number0140241001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L01FA01 RITUXIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
RITUXIMABActive
Strength: 10 MG / ML
Monograph: RITUXIMAB